Mr. Chair, on the question of a vaccine and whether Canada is doing all it can to be there, I would say there's massive investment right now. I think the issue is the concern about the diversity of the investment. That's one thing.
The other concern is making sure that we are following through on the money when we have invested such a massive amount. On Gavi, the reality is that it's about regular vaccinations, but it still gives a better voice. We need to make sure we have a strategy and a recommendation about R and D and how it will be used.
Right now, I'm not totally convinced that the follow-through is done. There's no.... Maybe it's done and it's not yet public, but I think this is something that needs to be followed through.